Moreover, analysis of KDELR1 expression in skin cutaneous melanoma patients (TCGA) showed, unlike KDELR3, no significant difference between early- and late-stage metastatic melanoma patients (Fig. 7e). This evidence concerns the gene KDELR1 and cutaneous melanoma.